Stockscreener 앱 받기
33.57
0.03%
-0.010
시간 외 거래:
33.87
0.30
+0.89%
전일 마감가:
$33.58
열려 있는:
$33.72
하루 거래량:
891.75K
Relative Volume:
1.81
시가총액:
$1.54B
수익:
$1.15B
순이익/손실:
$23.09M
주가수익비율:
67.14
EPS:
0.5
순현금흐름:
$89.18M
1주 성능:
+7.94%
1개월 성능:
+10.25%
6개월 성능:
+7.39%
1년 성능:
-30.98%
1일 변동 폭
$32.73
$34.36
1주일 범위
$29.09
$34.36
52주 변동 폭
$22.66
$53.31
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
OMCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
33.57 | 1.54B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Omnicell (NASDAQ:OMCL) Shares Gap UpStill a Buy? - MarketBeat
Omnicell (OMCL): Benchmark Raises Price Target to $45.00, Mainta - GuruFocus
Omnicell, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Landscape - Markets Mojo
Omnicell Q3 2025 slides: Medication management leader beats estimates, accelerates SaaS growth - Investing.com Australia
Omnicell (NASDAQ:OMCL) Releases FY 2025 Earnings Guidance - MarketBeat
Omnicell (NASDAQ:OMCL) Issues Q4 2025 Earnings Guidance - MarketBeat
Is Omnicell Inc. stock a safe buy before earningsQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
What Wall Street predicts for Omnicell Inc. stock priceQuarterly Earnings Report & Reliable Volume Spike Trade Alerts - newser.com
How Omnicell Inc. (OC9) stock reacts to new regulationsPortfolio Return Report & High Accuracy Swing Entry Alerts - newser.com
Will Omnicell Inc. outperform the market2025 Short Interest & Free Growth Oriented Trading Recommendations - newser.com
Why Omnicell Inc. stock could outperform in 2025July 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Central Fill Pharmacy Automation Market Projections - openPR.com
Will Omnicell Inc. stock maintain dividend yieldJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Omnicell Surpasses Q3 2025 Financial Expectations - TipRanks
Using data filters to optimize entry into Omnicell Inc.2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Omnicell: Q3 Earnings Snapshot - CT Insider
Why Omnicell Stock Crushed the Market Today - The Motley Fool
Omnicell Inc (OMCL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Investing.com Canada
Omnicell Inc (OMCL) Q3 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Omnicell Q3 2025 Earnings: Revenue & Profit Beat Estimates, Stock JumpsNews and Statistics - IndexBox
Why Omnicell (OMCL) Stock Is Trading Up Today - Yahoo Finance
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025. - MarketScreener
Omnicell Q3 2025 slides: Medication management leader beats estimates, accelerates SaaS growth By Investing.com - Investing.com South Africa
Omnicell shares climb 4% after strong Q3 beat and raised 2025 outlook - MSN
Omnicell (OMCL) Shares Cross Above 200 DMA - Nasdaq
Earnings call transcript: Omnicell’s Q3 2025 earnings beat expectations, stock surges - Investing.com
Omnicell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates - sharewise.com
Omnicell Outpaces Expectations With Strong Q3 Growth And Upgrades - Finimize
Omnicell Announces Third Quarter 2025 Financial Results - BioSpace
Omnicell, Inc. Updates Earnings Guidance for the Full Year 2025 - MarketScreener
Omnicell (OMCL) Projects Increased Revenue for 2025 - GuruFocus
Omnicell (OMCL) Exceeds Q3 Revenue Expectations - GuruFocus
Omnicell (OMCL) Forecasts Strong Q4 Revenue Despite Market Expec - GuruFocus
Omnicell, Inc. Provides Earnings Guidance for the Fourth Quarter 2025 - MarketScreener
Omnicell shares rise 4% after beating Q3 expectations, raising guidance By Investing.com - Investing.com Nigeria
Omnicell shares rise 4% after beating Q3 expectations, raising guidance - Investing.com
Omnicell : Investor Presentation – October 2025 - MarketScreener
Omnicell Q3 adjusted EPS beats estimates, driven by connected devices and services - MarketScreener
Omnicell Inc (OMCL) Q3 2025 Earnings: EPS of $0.51 Beats Estimat - GuruFocus
Earnings Flash (OMCL) Omnicell, Inc. Posts Q3 Adjusted EPS $0.51 per Share, vs. FactSet Est of $0.36 - MarketScreener
Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars - Yahoo Finance
Earnings Flash (OMCL) Omnicell, Inc. Reports Q3 Revenue $310.6M, vs. FactSet Est of $295.6M - MarketScreener
(OMCL) Omnicell, Inc. Expects Q4 Revenue Range $306.0M$316.0M - MarketScreener
How Omnicell Inc. stock performs in stagflation2025 Year in Review & Stock Portfolio Risk Control - newser.com
Omnicell, Inc. Experiences Revision in Stock Evaluation Amid Competitive Market Landscape - Markets Mojo
Omnicell (OMCL): Assessing Valuation After Recent 2% Share Price Dip - Yahoo Finance
Central Fill Pharmacy Automation Market See Incredible Growth 2025-2032 | Omnicell, Inc. and McKesson Corporation - openPR.com
Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Automated trading signals detected on Omnicell Inc.Wall Street Watch & Verified Momentum Stock Watchlist - newser.com
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.38%
0.07%
자본화:
|
볼륨(24시간):